Literature DB >> 35809207

Prediction of cellular targets in diabetic kidney diseases with single-cell transcriptomic analysis of db/db mouse kidneys.

Chenhua Wu1,2, Yingjun Tao2, Nan Li1,3, Jingjin Fei2, Yurong Wang1, Jie Wu4, Harvest F Gu5.   

Abstract

Diabetic kidney disease is the leading cause of impaired kidney function, albuminuria, and renal replacement therapy (dialysis or transplantation), thus placing a large burden on health-care systems. This urgent event requires us to reveal the molecular mechanism of this disease to develop more efficacious treatment. Herein, we reported single-cell RNA sequencing analyses in kidneys of db/db mouse, an animal model for type 2 diabetes and diabetic kidney disease. We first analyzed the hub genes expressed differentially in the single cell resolution transcriptome map of the kidneys. Then we figured out the communication among the renal and immune cells in the kidneys. Data from this report may provide novel information for better understanding the cell-specific targets involved in the aetiologia of type 2 diabetic kidney disease and for cell communication and signaling between renal cells and immune cells of this complex disease.
© 2022. The International CCN Society.

Entities:  

Keywords:  Diabetes; Diabetic kidney disease; End-stage renal disease; Proximal epithelial tubular cells; Single-cell RNA sequencing

Year:  2022        PMID: 35809207     DOI: 10.1007/s12079-022-00685-z

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  39 in total

Review 1.  CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease.

Authors:  Hans-Joachim Anders; Tobias B Huber; Berend Isermann; Mario Schiffer
Journal:  Nat Rev Nephrol       Date:  2018-06       Impact factor: 28.314

2.  Single-Cell RNA Profiling of Glomerular Cells Shows Dynamic Changes in Experimental Diabetic Kidney Disease.

Authors:  Jia Fu; Kemal M Akat; Zeguo Sun; Weijia Zhang; Detlef Schlondorff; Zhihong Liu; Thomas Tuschl; Kyung Lee; John Cijiang He
Journal:  J Am Soc Nephrol       Date:  2019-03-07       Impact factor: 10.121

Review 3.  Diagnosis and Management of Type 2 Diabetic Kidney Disease.

Authors:  Simit M Doshi; Allon N Friedman
Journal:  Clin J Am Soc Nephrol       Date:  2017-03-09       Impact factor: 8.237

Review 4.  Biomarkers for drug-induced renal damage and nephrotoxicity-an overview for applied toxicology.

Authors:  Tobias Christian Fuchs; Philip Hewitt
Journal:  AAPS J       Date:  2011-10-04       Impact factor: 4.009

5.  MicroRNA-214 promotes chronic kidney disease by disrupting mitochondrial oxidative phosphorylation.

Authors:  Mi Bai; Huimei Chen; Dan Ding; Ruihua Song; Jiajuan Lin; Yuanyuan Zhang; Yan Guo; Shuang Chen; Guixia Ding; Yue Zhang; Zhanjun Jia; Songming Huang; John Cijiang He; Li Yang; Aihua Zhang
Journal:  Kidney Int       Date:  2019-03-05       Impact factor: 10.612

6.  Immuno-localization of CD44 and osteopontin in developing human kidney.

Authors:  Giovanna M Crisi; Sharon A Marconi; Gary F Rockwell; Gregory L Braden; Thomas J Campfield
Journal:  Pediatr Res       Date:  2009-01       Impact factor: 3.756

Review 7.  PCK1 and PCK2 as candidate diabetes and obesity genes.

Authors:  Elmus G Beale; Brandy J Harvey; Claude Forest
Journal:  Cell Biochem Biophys       Date:  2007       Impact factor: 2.194

8.  Butyrate alleviates diabetic kidney disease by mediating the miR-7a-5p/P311/TGF-β1 pathway.

Authors:  Yi Du; Yi-Tong Yang; Gang Tang; Jie-Shuang Jia; Nan Zhu; Wei-Jie Yuan
Journal:  FASEB J       Date:  2020-06-15       Impact factor: 5.191

9.  Kidney Androgen-Regulated Protein (KAP) Transgenic Mice Are Protected Against High-Fat Diet Induced Metabolic Syndrome.

Authors:  Beatriz Bardaji de Quixano; Josep A Villena; Miguel Aranda; Gemma Brils; Antoni Cuevas; Théana Hespel; Haizea Lekuona; Cristina Súarez; Olga Tornavaca; Anna Meseguer
Journal:  Sci Rep       Date:  2017-11-23       Impact factor: 4.379

Review 10.  Role of Neuropilin-1 in Diabetic Nephropathy.

Authors:  Tzvetanka Bondeva; Gunter Wolf
Journal:  J Clin Med       Date:  2015-06-17       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.